Crohn's disease in children frequently involves the terminal ileum, the site of bile acid active transport.2 Several studies have suggested that ileal inflammation may interfere with the enterohepatic circulation of bile acids.38 Our aim in this study was to assess ileal function in patients with Crohn's disease by measuring the meal stimulated response of the serum bile acid concentration. The advent of reliable radioimmunoassays for bile acids in serum allows investigation of bile acid pathophysiology in intestinal disease, as the small changes in concentration that occur in the postprandial state can be precisely measured.9 -12 Methods SUBJECTS Twenty consecutive patients with Crohn's disease were studied. Ten patients (nine children with an age range of 9 to 17 years and one adult, aged 34 years) had newly diagnosed, untreated Crohn's disease. Radiographic abnormalities involved the terminal *Presented in part at the annual meetingIof the American Gastroenterological Association, New Orleans, LA, 23 May 1979, and published in abstract form. ' tAddress for correspondence: W F Balistreri, Children's Hospital Research Foundation, Elland and Bethesda Avenues, Cincinnati, Ohio 45229, USA.
Received for publication 12 May 1981 ileum in seven patients and were limited to the upper small bowel in three patients. In this group disease activity was assessed by the National Cooperative Study Crohn's Disease Activity Index, in which a value greater than 150 indicates active disease.t3 The mean score in these patients was 2431 + 19-3 (x+ SEM) at the time of the study; however, this index may possibly underestimate disease activity in some children in whom severe growth failure may be the only manifestation of Crohn's disease.
Ten patients with previously diagnosed Crohn's disease (nine children with an age range of 10 to 18 years, and one adult, aged 32 years) under standard medical thereapy for longer than six months were also studied. All patients in this group had abnormalities of the terminal ileum on radiography and none had undergone intestinal resection. Seven of these patients were studied during a period of continuing disease; three patients were completely asymptomatic.
Comparison groups included 16 healthy subjects (age range of 2 to 16 years); six patients with variable lengths of ileal resection for non-inflammatory bowel disease (age range 2 to 19 years), and seven patients with ulcerative colitis (age range 2 to 15 years). Five of the patients with colitis had symptoms with cramps and diarrhoea at the time of the study, and two of these patients had changes of 'backwash' ileitis on contrast radiographs.
Informed consent was obtained from the parents and subjects before taking part in the study. The data were expressed as mean values plus or minus the standard error of the mean. The fasting baseline for each subject was determined by averaging the values obtained at the -30 and 0 time points. The peak concentration (maximum rise above baseline) achieved by each individual at any time point was ascertained, a mean peak concentration for each group was calculated, and differences between groups were determined using analysis of variance. 7 The areas under the meal response curves were calculated with the aid of a computer programme. The mean peak times and areas under the curves were compared using Duncan's multiple range test. 18 
Results
The meal response curve for patients with newly diagnosed, untreated ileal Crohn's disease is compared with the profile obtained in normal children (Fig. 1) . The mean peak rise above the fasting baseline for the seven patients with radiological ileal involvement was 0-4+0±05 pmol/l for cholylglycine (Fig. 2) ; the increase in total serum bile acid concentration was 2 1+0-5 pmol/l in the five patients studied (Fig. 3) . These responses were similar to those seen in patients with ileal resection who had a mean peak rise in cholylglycine concentration of 0-3+0-09 Mmol/l and a rise in the total serum bile acid concentration of 2 2 +0-8 imol/l.
A significantly (p <0-01) greater response occurred in 16 normal subjects, with a mean peak postprandial cholylglycine rise of 1-8 + 0-18 Mmol/l (Fig. 2) . In a similar fashion, the mean total serum bile acid concentration rose postprandially by 9 8 + 2 4 imol/l in 11 of these subjects (P<0-025) (Fig. 3) . In children with ulcerative colitis, the rise in cholylglycine of 22 ±+06 ,mol/l was not significantly different from controls. In patients with newly diagnosed Crohn's disease in whom there was no radiological evidence of terminal ileal involvement the postprandial response was also similar to controls.
In the 10 patients with Crohn's disease treated for longer than six months (Fig. 2) , the mean increase in cholylglycine concentration (04+0±06 pmol/l) was also significantly (P<0 01) different from normal. However, in two of three asymptomatic patients in this group, a normal postprandial rise occurred. The mean peak response of the total serum bile acid concentration in seven treated patients was 22 +0 5 umol/l (P<0-025); the maximum increases in two asymptomatic subjects from this group were not significantly different from the patients with active disease.
When all 14 patients with active Crohn's disease involving the terminal ileum are considered together, the maximum rise above baseline in cholylglycine concentration was 0 4+0004 ,mol/l (P<0 01); total serum bile acid concentration rose 20+0±4 ymol/l (P<0 025) in the 10 patients studied. There was no overlap in the mean values obtained in patients with active treated or untreated ileal disease and normal controls. There was no overlap seen in the mean response of patients with symptomatic colitis, including two patients with 'backwash' ileitis, or of patients with active Crohn's disease.
Examination of the meal response curves from the patients with active ileal Crohn's disease, from patients with active colitis, and from normal subjects revealed no significant differences in the mean time to the peak in the serum cholylglycine concentration (1-69+0-25 2 08+014 and 168+0 21 hours respectively). The integrated area under the meal response curve was similar in the colitis and normal groups (5 4 + 1 4 and 3 9 + 0 7 ,mol/l/h respectively, P not significant) but significantly less in the Crohn's disease patients (1-3 +0 26 ,umol/l/h, P<0 01).
Discussion
This study shows that ileal inflammation in Crohn's disease may interfere with the expected postprandial rise in the serum bile acid concentration. In all patients with active ileal disease, both the mean peak increase in the serum cholylglycine concentration and the integrated area under the meal response curve were significantly different from that seen in controls and similar to results obtained in patients with ileal resection. The findings are apparently specific for ileal dysfunction, as a normal rise in serum bile acid levels occurred in patients with Crohn's Crohn's disease.7 The ratio of glycine to taurine conjugates was greater in these patients than in normal subjects, reflecting excess bile acid loss. The bile acid pool size was significantly decreased and, of all laboratory parameters, this change correlated best with disease activity as assessed by the National Cooperative Crohn's Disease Study Activity Index.13 Extent of disease as defined radiographically did not correlate with the activity score. Unfortunately, in this study there was considerable and unexplained overlap in pool size between patients with Crohn's disease and ulcerative colitis.
Alterations in the enterohepatic circulation of bile acids may be characterised from a number of vantage points; the numerous methods vary in their sensitivity, specificity, and ease of clinical application. Previous work has suggested that involvemen.t of receptor sites for the active reabsorption of bile acids may occur in ileitis before more commonly regarded abnormalities are detectable. We chose to measure serum bile acid concentrations in Crohn's disease; our hypothesis being that, in the presence of ileal injury, less bile acid would enter peripheral blood in the postprandial state, and that this abnormality could be quantified and differentiated from the meal response in normal subjects.
The cholylglycine assay is particularly suited for use as a test of ileal function, as this compound relies predominantly on ileal active transport for reabsorption.23 Less polar bile acid species can be absorbed throughout the small intestine by passive transport mechanisms. This phenomenon might obscure subtle changes in the enterohepatic circulation when the total serum bile acid concentration is measured. In our study, total serum bile acid levels, as determined by the enzymatic assay, did afford satisfactory, but less striking, discrimination between the Crohn's disease group and normal subjects. In view of the possibility of false negative results and the cumbersome nature of the methodology, this assay seems less suited for clinical application.
We studied all patients after a 12 hour fast to ensure a best response after meal stimulated gallbladder contraction. The time required to reach a peak in the serum cholylglycine concentration is similar in all patient groups and suggests comparable intraluminal events such as gallbladder emptying and transit to the terminal ileum. The maximum rise in serum bile acid concentration is sufficient to distinguish all patients with active ileal Crohn's disease from normal subjects. The integrated area under the meal curve has been used by several investigators to compare the response of various patient groups,9 12 but in our study was not more sensitive than the easily derived peak concentration in detecting ileal dysfunction. It is possible that discrimination may be further enhanced by studying patients over a 24 hour period or after the third meal of the day to follow depletion of the bile acid pool, as might occur with each successive meal in patients with ileal dysfunction.9 Deconjugation of bile acids from bacterial overgrowth of the small intestine could also decrease the postprandial serum bile acid response; additional study of this problem is warranted in Crohn's disease. Samuelson and associates have recently suggested that liver dysfunction in some patients with Crohn's disease could lead to raised fasting and postprandial serum bile acid levels and thereby invalidate the use of this measurement as a test of ileal inflammation.24 However, their group of patients is not comparable with our study population in that they had all previously undergone distal ileal resection. In addition, there is no attempt to correlate the meal response with Crohn's disease activity. It is possible that in the presence of mild liver dysfunction an accurate assessment of ileal integrity may still be obtained through observation of the rise above the fasting baseline instead of the absolute serum bile acid concentration.
In conclusion, our preliminary observations support the concept of an altered enterohepatic circulation of bile acids in Crohn's disease as has been suggested by previous studies.25 The defect in bile acid absorption is apparently specific for ileal involvement and active disease. Analysis of the postprandial serum bile acid response may be useful in evaluating insidious systemic and gastrointestinal complaints which may be seen in childhood ileitis. Additional studies are needed to judge the clinical usefulness of this determination in the diagnosis and serial assessment of patients with Crohn's disease. ever-expanding subject which, from early student days, often seems to be clouded by mystique.
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